Discovery Partners to Acquire Xenometrix | GenomeWeb

NEW YORK, Feb 28 – Discovery Partners International, a  San Diego-based provider of diverse drug discovery services, has agreed to acquire the gene profiling technology company Xenometrix for $1.7 million, the companies said Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.